XTANT MEDICAL HOLDINGS, INC. (XTNT)

Import this data to Google Sheets with:

=jivedata("XTNT","financials")

Full statements spill as a table. For one cell: =jivedata("XTNT","Revenue") or =jivedata("XTNT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

XTANT MEDICAL HOLDINGS, INC.

XTNT • CIK 0001453593

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cost of Goods and Services Sold	$35,836	$49,051	$49,654	$44,480
Gross Profit	$55,467	$68,216	$84,273	$65,047
Operating Income (Loss)	$-10,158	$-12,074	$7,284	$-10,495
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-1,037	$-16,262	$7,001	$-9,239
Income Tax Expense (Benefit)	$-1,697	$187	$2,028	$1,898
Net Income (Loss) Attributable to Parent	$660	$-16,449	$4,973	$-11,137
Revenue from Contract with Customer, Excluding Assessed Tax	$91,303	$117,267	$133,927	$109,527
General and Administrative Expense	$25,850	$28,691	$29,375	$27,073
Selling and Marketing Expense	$38,439	$49,214	$45,512	$41,246
Research and Development Expense	$1,336	$2,385	$2,102	$2,223
Operating Expenses	$65,625	$80,290	$76,989	$75,542
InterestExpenseNonoperating	—	$4,160	$3,671	$2,763
Investment Income, Interest	$149	$149	$94	$94
Foreign Currency Transaction Gain (Loss), Unrealized	$265	$5	$-60	$-240
Gain (Loss) on Disposition of Stock in Subsidiary	—	—	$3,281	$3,281
Other Nonoperating Income (Expense)	—	$-33	$73	$664
Nonoperating Income (Expense)	$9,121	$-4,188	$-283	$1,256
Weighted Average Number of Shares Outstanding, Basic	119,093,687	133,665,075	139,531,791	140,500,668
Weighted Average Number of Shares Outstanding, Diluted	126,793,318	133,665,075	150,042,556	141,862,388
Weighted Average Number of Shares, Restricted Stock	2,447,519,000	2,447,519,000	5,434,407	5,434,407
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants	5,252,112,000	5,252,112,000	5,076,358	5,076,358

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$5,715	$6,199	$17,053	$9,870
Restricted Cash, Current	$208	$22	$275	$347
Property, Plant and Equipment, Net	$8,692	$10,131	$6,202	$5,542
Accounts Receivable, after Allowance for Credit Loss, Current	$20,731	$20,660	$17,803	$19,416
Operating Lease, Right-of-Use Asset	$1,523	$829	$3,192	$2,894
Inventory, Net	$36,885	$38,634	$30,263	$33,287
Goodwill	$7,302	$7,302	$6,074	$6,074
Financing Receivable, after Allowance for Credit Loss, Current	—	—	$10,462	$10,462
Intangible Assets, Net (Excluding Goodwill)	$10,085	$8,356	$299	$252
Prepaid Expense and Other Assets, Current	$1,330	$1,601	$2,389	$1,857
Other Assets, Noncurrent	$141	$103	$133	$128
Assets, Current	$64,869	$67,116	$78,245	$64,777
Assets	$92,612	$93,837	$94,145	$79,667
Additional Paid in Capital	$294,330	$302,738	$305,439	$307,004
Accumulated Other Comprehensive Income (Loss), Net of Tax	$29	$-316	$-316	$-1
Retained Earnings (Accumulated Deficit)	$-243,010	$-259,459	$-254,486	$-266,988
Stockholders' Equity Attributable to Parent	$51,349	$42,963	$50,953	$40,015
Accounts Payable, Current	$7,054	$7,918	$3,844	$6,154
Accrued Liabilities, Current	$10,419	$7,771	$10,626	$7,481
Long-term Debt, Current Maturities	$2,333	—	$3,500	$3,720
Operating Lease, Liability, Current	$830	$703	$622	$594
Finance Lease, Liability, Current	$65	$69	$35	$29
Line of Credit, Current	$4,622	$12,120	$10,857	$11,985
Liabilities, Current	$22,990	$28,581	$29,484	$29,963
Operating Lease, Liability, Noncurrent	$759	$166	$2,665	$2,397
Finance Lease, Liability, Noncurrent	$116	$47	$12	$3
Long-term Debt, Excluding Current Maturities	$17,167	$22,038	$11,026	$7,287
Deferred Income Tax Liabilities, Net	$21	$42	$5	$5
Liabilities	$41,263	$50,874	$43,192	$39,652
Accounts and Financing Receivable, Allowance for Credit Loss	—	$1,437	$2,165	$2,234
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	130,180,031	139,045,664	140,039,557	140,262,960

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$660	$-16,449	$4,973	$-11,137
Net Cash Provided by (Used in) Operating Activities	$-9,515	$-11,896	$12,546	$570
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$24	$-149	$232	$252
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-14,584	$298	$11,107	$3,180
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$5,923	$6,221	$17,328	$24,050
Depreciation, Depletion and Amortization	$3,174	$4,224	$5,223	$4,022
Payments to Acquire Property, Plant, and Equipment	$1,456	$4,113	$2,382	$1,266
Proceeds from Sale of Property, Plant, and Equipment	$175	$383	$232	$237
Gain (Loss) on Disposition of Assets	$115	$264	$-251	$-305
Share-based Payment Arrangement, Noncash Expense	$2,739	$4,117	$2,892	$2,989
Net Cash Provided by (Used in) Investing Activities	$-24,784	$-3,730	$7,899	$14,388
Inventory Write-down	$357	$485	$3,669	$4,675
Gain (Loss) on Disposition of Stock in Subsidiary	—	—	$3,281	$3,281
Proceeds from Lines of Credit	$78,219	$112,640	$100,066	$76,149
Repayments of Lines of Credit	$76,976	$105,142	$101,329	$76,171
Repayments of Long-term Debt	—	—	$8,000	$8,000
Finance Lease, Principal Payments	$63	$65	$67	$51
Proceeds from Issuance of Private Placement	—	$4,456	$-65	$-65
Proceeds from Issuance of Long-term Debt	$4,761	$5,000	$5,000	$5,000
Payments of Debt Issuance Costs	—	$651	$49	$49
Proceeds from Stock Options Exercised	—	$13	$13	$13
Net Cash Provided by (Used in) Financing Activities	$19,691	$16,073	$-9,570	$-12,030
Cash and Cash Equivalents, at Carrying Value	$5,715	$6,199	$17,053	$24,158
Restricted Cash and Cash Equivalents	$208	$22	$275	$-108
Increase (Decrease) in Accounts Receivable	$8,736	$755	$591	$-4,206
Increase (Decrease) in Inventories	$1,886	$2,494	$1,999	$4,241
Increase (Decrease) in Prepaid Expense and Other Assets	$-220	$218	$1,537	$2,182
Increase (Decrease) in Accounts Payable	$2,980	$1,033	$-3,117	$72
Increase (Decrease) in Accrued Liabilities	$3,788	$-2,915	$4,198	$-1,710

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("XTNT","financials")

Full statements spill as a table. For one cell: =jivedata("XTNT","Revenue") or =jivedata("XTNT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.